Michael Brandkamp has departed from its managing director role at corporate-backed fund HTGF to become a general partner European Circular Bioeconomy Fund.

Today’s deal net captures the smaller investments from across the university innovation ecosystem over the past two weeks.

The University of Oxford DNA processing spinout tapped a consortium of unnamed investors in a round which also includes $106m in secondary funding.

Canadian Imperial Bank of Commerce contributed to the digital accounting platform developer's series C round, taking its total funding past $130m.

The Illumina and Amgen-backed genetic sequencing system developer raised $38.5m while its shareholders sold another $106m in shares.

In an extended version covering the holidays, Global Corporate Venturing has rounded up the period’s smaller deals and tracked the emerging companies accessing corporate funds.

Guerbet, Caisse Centrale de Réassurances, L’Occitane and Sopra Steria were among the backers for the life sciences-focused venture firm's BioMedTech fund.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Axel Johnson's Novax unit has backed Uppsala University materials spinout Disruptive Materials, which last raised funding in 2016.

BioMedTech will work to establish approximately a dozen spinouts from European and American universities, with a particular focus on France.